Search Results for 'immuno-oncology'
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration
3SBio will fund and conduct antibody development and GMP manufacturing02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
Takeda Enters Immuno-Oncology Collaborations
Accelerating the discovery of next-generation cancer immunotherapies01.03.19
-
Gilead, Agenus Enter Immuno-Oncology Pact
Aims to develop and commercialize up to five novel immuno-oncology therapies12.20.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
TRACON & I-Mab Partner for Immuno-Oncology
TRACON to be responsible for the regulatory & clinical development of I-Mab's TJD5 & up to five of the BsAbs in North America11.29.18
-
Collaborations & Alliances | Drug Discovery
CrownBio, Pierre Fabre In Immuno-Oncology Alliance
CrownBio to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models06.19.18
-
Drug Discovery
Developing a Translational Immuno-oncology Platform
The critical bridge supporting a project’s transition from the bench to clinicMartin O’Rourke, Ph.D., Senior Director, Oncology In Vitro Biosciences, Integrated Drug Discovery at Charles River 05.03.18
-
Drug Development | Drug Discovery | Industry News | Promotions & Moves
Lilly Hires Immuno-Oncology Lead
Dr. Leena Gandhi was most recently director of Thoracic Medical Oncology and an associate professor of medicine at NYU04.30.18
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery
Catalent, Grid Therapeutics in Immuno-Oncology Alliance
Will leverage GPEx cell line technology to develop cell lines and manufacture antibodies for optimization10.30.17
-
Clinical Trials | Collaborations & Alliances | Drug Development
Lilly, Merck Expand Immuno-Oncology Alliance
Adds new study of LARTRUVO with KEYTRUDA in previously treated advanced or metastatic soft tissue sarcoma01.11.17
-
Clinical Trials | Collaborations & Alliances | Drug Development
BMS, Janssen Enter Immuno-Oncology Alliance
To evaluate Opdivo and Darzalex in Phase Ib/II trials in multiple myeloma and solid tumors01.05.17
